中文 | English
Return
Total: 3667 , 1/367
Show Home Prev Next End page: GO
Author:( duan, LI)

1.Treatment progress and nutritional assessment for the patients with gastrointestinal neoplasms during perichemotheraputic period

Yingxin DUAN ; Junling LI

Journal of International Oncology 2013;40(11):858-861

2.Experimental study on the cell culture and secretory function of parathyroid cells in rats

Xiuqing DUAN ; Yongning LI

Chinese Journal of Current Advances in General Surgery 2004;0(05):-

3.Effects of cyclophosphamide on pharmacokinetics of buthionine sulfoximine in Walker-256 tumor-bearing rats

Chunling FAN ; Duan LI ;

Chinese Pharmacological Bulletin 1987;0(02):-

4. Electrochemical method in determination of bupivacaine hydrochloride content in bupivacaine bydrochloride raw medicine

Duan LI

Academic Journal of Second Military Medical University 2010;31(7):794-795

5.Expression of Survivin in Human osteosarcoma and its correlation with PTEN and cyclinD1

Guoqing DUAN ; Shuzhong LI

Orthopedic Journal of China 2006;0(03):-

6.Clinical Observation of Diltiazem Combined with Cyclosporine in the Treatment of Nephrotic Syndrome Complicated with Acute Renal Injury

Yanjuan LI ; Xiaojun DUAN

China Pharmacy 2017;28(18):2503-2506

7.Progress of diagnosis and treatment of drug induced liver injury in children

Qingming'ai DUAN ; Zhongyue LI ;

Chinese Journal of Applied Clinical Pediatrics 2016;31(7):554-556

8.Survey on the effect of resident training in clinical skills on SARS prevention and treatment

Xi DUAN ; Darong LI ;

Chinese Journal of Hospital Administration 1996;0(05):-

9.Advance in the pharmacology of buthionine salfoximine

Chunling FAN ; Duan LI

Chinese Pharmacological Bulletin 1998;0(S1):-

10.Comprehensive Fuzzy Assessment on Sanitary Quality of Public Places of Entertainment in Taiyuan During 1998~2000

Qing DUAN ; Jinfen LI

Journal of Environment and Health 1989;0(06):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3667 , 1/367 Show Home Prev Next End page: GO